SAFE vs Priced Round: Which Should You Raise?

Every founder eventually faces the question: should this round be a SAFE, a convertible note, or a priced equity round? The answer changes how much paperwork you do, what your cap table looks like, what investors expect, and how easy your next round will be.

This article explains all three, with clear guidance on when each is appropriate.

The short version

• SAFE. A simple agreement giving an investor the right to convert their cheque into equity at a future priced round, usually with a valuation cap and/or discount. No interest, no maturity. Best for pre-seed and small seed rounds.
• Convertible note. Like a SAFE, but with interest and a maturity date. Slightly more legal complexity. Less common in 2026 in the US; still common in some markets and for specific situations.
• Priced round. A formal share issuance at a fixed valuation. Full term sheet, definitive documents, a board, governance. Standard at Series A; increasingly common at seed.

For most pre-seed and early seed rounds in 2026, SAFEs are the default. For Series A and later, priced is the standard. The middle ground — late-stage seeds — varies.

SAFEs: what they actually are

SAFE stands for Simple Agreement for Future Equity. Created by Y Combinator in 2013, it's a one-to-three-page document that says, roughly: I'm giving you $X today; in exchange, when you next raise a priced equity round, this $X converts into shares at terms defined here.

A SAFE has two main economic levers:

Valuation cap. The maximum valuation at which the SAFE will convert. If your next round prices at $30m and your SAFE has a $20m cap, the SAFE investor converts as if the company were worth $20m — they get more shares per dollar than the new round investors. This rewards them for investing earlier.

Discount. A percentage discount on the next round's price (commonly 15–25%). If your next round prices at $30m and your SAFE has a 20% discount, the SAFE investor converts at $24m equivalent. Discounts can stack with caps (the investor takes whichever is more favourable).

A SAFE typically has both a cap and a discount, though some have only one. The original YC SAFE had no cap and just a discount; modern post-money SAFEs almost always include a cap.

Pre-money vs post-money SAFEs

A subtle but important distinction. Original SAFEs were "pre-money" — the cap referred to the company's valuation before the SAFE money was added. The post-money SAFE (the modern YC default since 2018) treats the cap as the company's valuation after all SAFEs convert. The post-money SAFE is more predictable for both sides; pre-money SAFEs introduced confusing dilution surprises.

Most US fundraises in 2026 use post-money SAFEs. Some UK and EU equivalents (ASAs in the UK) handle this differently.

Why founders like SAFEs

• Fast: a few pages, signed in days.
• Cheap: minimal legal cost.
• No board seats, no protective provisions, no governance overhead.
• Investors don't get most preferred-share rights until conversion.

Why investors sometimes resist SAFEs

• Less formal protection than priced rounds.
• Conversion can produce surprising dilution if not carefully modelled.
• Stacking many SAFEs can make a future priced round complicated.

In practice, almost all institutional pre-seed and early seed investors will accept SAFEs. Some seed leads (especially European funds) prefer priced from $1.5m+.

Convertible notes: the older cousin

Convertible notes are similar to SAFEs but with two differences:

• Interest. Notes accrue interest (typically 4–8% annually) that converts into additional equity at the next round.
• Maturity date. Notes have a maturity date (usually 18–24 months) by which they must convert or be repaid. If they hit maturity before a priced round, the investor and company have to negotiate.

In the US, SAFEs largely replaced convertible notes after 2018. Notes are still common in some markets (parts of Europe, parts of Asia, traditional debt-style angel investing) and in specific situations (e.g., a structured bridge round between priced rounds).

Priced rounds: full equity

A priced round is a formal share issuance. The company creates a new class of preferred shares, sets a valuation, and sells the new shares to investors. Comes with:

• A full term sheet (see what is a term sheet).
• Definitive documents (Stock Purchase Agreement, Investor Rights Agreement, Voting Agreement, etc.).
• A board (usually with at least one investor seat).
• Liquidation preference, anti-dilution, pro rata rights, protective provisions, etc.

Time and cost: 4–8 weeks of legal work. $25k–$75k in legal fees (usually paid by the company, often capped). Heavier than a SAFE round but produces a clean cap table and the formal governance investors and lawyers prefer for serious rounds.

When to use which

Three rough rules.

Pre-seed rounds: SAFE

SAFEs are nearly universal at pre-seed. The round is small, the legal cost of a priced round isn't worth it, and investors know they'll get formalised at the next round. Use post-money SAFEs with a cap and ideally a small discount.

Seed rounds under $3m: SAFE (probably)

A $1.5m–$3m seed can run on SAFEs and often does. Faster, cheaper, simpler. The lead investor may push for a priced round instead — depends on the lead.

Seed rounds $3m+: priced (probably)

At larger seed rounds, the lead investor often wants a priced round. The legal overhead is justified by the larger cheque. You'll have a board observer or board seat, full term sheet structure, and proper governance.

Series A and later: always priced

By Series A, priced rounds are essentially mandatory. The cheques are too large for SAFEs, the institutional investors require formal protections, and the cap table needs to be cleanly structured for future rounds.

SAFE stacking: a real concern

A pattern that catches founders out: raising multiple SAFEs at different caps without modelling the cumulative dilution.

Example: you raise:

• $500k SAFE at $5m cap
• $500k SAFE at $7m cap
• $500k SAFE at $10m cap
• $1m SAFE at $12m cap

Then you raise a $4m priced round at a $20m post-money valuation.

When the SAFEs convert at their caps, the dilution can be substantially more than the founder modelled. With four SAFEs at four different caps, the maths gets non-trivial.

The fix:

• Use a SAFE conversion model (Carta and others provide them).
• Model the conversion before signing the SAFE, not after.
• Be conservative when stacking: each new SAFE pre-emptively dilutes you more than it looks.

We have a piece on this: valuation and dilution explained.

What about UK ASAs?

The UK uses Advance Subscription Agreements (ASAs) instead of SAFEs for SEIS/EIS-eligible rounds. Functionally similar to SAFEs, but with a longstop date (typically 6 months) by which the priced round must occur. ASAs maintain SEIS/EIS eligibility; SAFEs may not. We cover this in raising VC in the UK.

A practical checklist

Before signing any of these instruments:

1. Use a standard, well-known form. YC's post-money SAFE for the US; British Business Bank ASA template for the UK; standard convertible note forms for other markets.
2. Model the conversion at multiple future round scenarios.
3. Don't stack many different SAFEs at many different caps; consolidate where possible.
4. Have a startup lawyer review at minimum the first SAFE you sign — even though they're "standard", small variations matter.
5. Keep a clean record of every SAFE signed, with cap, discount, and date.

The instrument you choose is a signal as much as a structure. SAFEs say "we're moving fast and keeping it simple". Priced rounds say "we're treating this as a major capital event with full governance". Pick the one that matches your round's reality, not the one that looks impressive.